These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage. Karti O; Karahan E; Acan D; Kusbeci T Int Ophthalmol; 2016 Dec; 36(6):845-849. PubMed ID: 26948127 [TBL] [Abstract][Full Text] [Related]
6. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage. Noda S; Hayasaka S; Setogawa T J Pediatr Ophthalmol Strabismus; 1991; 28(1):20-2. PubMed ID: 2019953 [TBL] [Abstract][Full Text] [Related]
7. [Different managements of congenital nasolacrimal duct obstruction]. Ma QY; Chen YZ; Liu AQ Yan Ke Xue Bao; 1985 Dec; 1(2):129-32. PubMed ID: 3880145 [No Abstract] [Full Text] [Related]
11. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents. Song HY; Jin YH; Kim JH; Sung KB; Han YM; Cho NC Radiology; 1994 Feb; 190(2):535-9. PubMed ID: 8284412 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting treatment outcome in congenital nasolacrimal duct obstruction: A retrospective analysis from South India. Bhandari S; Sengupta S; Yadalla D; Rajagopalan J; Velis GB; Talele D; Kushwaha S Indian J Ophthalmol; 2015 Oct; 63(10):759-62. PubMed ID: 26654998 [TBL] [Abstract][Full Text] [Related]
13. Success rates of primary probing for congenital nasolacrimal obstruction in children. Arora S; Koushan K; Harvey JT J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy. Ng DS; Chan E; Tong FM; Chow SK; Ko ST Orbit; 2016; 35(2):103-5. PubMed ID: 26838355 [TBL] [Abstract][Full Text] [Related]
15. Aquaporin expression in the lacrimal sac of patients with primary and functional nasolacrimal duct obstruction. Park J; Kim J; Kim M; Baek S Br J Ophthalmol; 2017 Apr; 101(4):519-524. PubMed ID: 27439740 [TBL] [Abstract][Full Text] [Related]
16. [Rosenmüller valve during endoscopic dacryocystorhinostomy in treating refractory nasolacrimal duct obstruction]. Wang M; Wang SQ; Zhang J; Li MW; Xing ZM; Yuan XP; Li H; Liu Y; Geng CL Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):522-7. PubMed ID: 27480301 [TBL] [Abstract][Full Text] [Related]
17. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness. Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928 [TBL] [Abstract][Full Text] [Related]
18. Evaluation and management of congenital nasolacrimal duct obstruction. Kapadia MK; Freitag SK; Woog JJ Otolaryngol Clin North Am; 2006 Oct; 39(5):959-77, vii. PubMed ID: 16982257 [TBL] [Abstract][Full Text] [Related]
19. [Progress in the treatment for nasolacrimal duct obstruction]. Zhang Q; Qian Y Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):108-9. PubMed ID: 11593619 [No Abstract] [Full Text] [Related]
20. Congenital nasolacrimal duct obstruction: Should we continue lacrimal massage till 1 year or perform an office probing at 6 months? A clinical decision analysis approach. Kothari M; Rathod V; Shah K; Shikhangi K; Singhania R Indian J Ophthalmol; 2017 Feb; 65(2):167-169. PubMed ID: 28345576 [No Abstract] [Full Text] [Related] [Next] [New Search]